Edwards Lifesciences sells critical care business to BD for $4.2B—remains ‘laser focused’ on structural heart disease

Healthcare M&A, mergers and acquisitions business deal.

This move represents a pivot of sorts for Edwards; instead of pursuing a spin-off of its critical care business, the company is now doubling down on its commitment to develop new structural heart technologies. BD, meanwhile, says the transaction will deliver significant value. 

Lung-RADS update helps limit false-positive results, unnecessary procedures

Lung cancer screening CT image in a 66-year-old male patient shows a sessile nodule with internal air in the left mainstem to left upper lobe bronchus (arrow) with a mean diameter of 10 mm. The nodule was assigned as Lung-RADS category 4A in the clinical report. (B) Follow-up CT image shows the lesion is resolved. Image courtesy of RSNA

Example image from the study from a Lung cancer screening CT image in a 66-year-old male patient. It shows a sessile nodule with internal air in the left mainstem to left upper lobe bronchus (arrow) with a mean diameter of 10 mm. The nodule was assigned as Lung-RADS category 4A in the clinical report. (B) Follow-up CT image shows the lesion is resolved. Image courtesy of RSNA

Using the latest version was associated with improved diagnostic accuracy, researchers wrote in a new analysis.